Susquehanna International Group
CYTK icon

Susquehanna International Group’s Cytokinetics CYTK Stock Holding History

Susquehanna International Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.2M Buy
898,951
+145,334
+19% +$9.24M 0.01% 1161
2025
Q4 		$47.9M Sell
753,617
-264,184
-26% -$16.4M 0.01% 1403
2025
Q3 		$55.9M Buy
1,017,801
+296,987
+41% +$12.2M 0.01% 1260
2025
Q2 		$23.8M Buy
720,814
+181,704
+34% +$6.32M ﹤0.01% 1826
2025
Q1 		$21.7M Buy
539,110
+399,993
+288% +$18.4M ﹤0.01% 1676
2024
Q4 		$6.54M Sell
139,117
-62,372
-31% -$3.24M ﹤0.01% 3198
2024
Q3 		$10.6M Buy
201,489
+44,450
+28% +$2.48M ﹤0.01% 2536
2024
Q2 		$8.51M Sell
157,039
-419,438
-73% -$25.3M ﹤0.01% 2696
2024
Q1 		$40.4M Sell
576,477
-59,025
-9% -$4.57M 0.01% 1183
2023
Q4 		$53.1M Buy
635,502
+470,916
+286% +$17.1M 0.01% 1000
2023
Q3 		$4.85M Buy
164,586
+58,529
+55% +$1.95M ﹤0.01% 3584
2023
Q2 		$3.46M Sell
106,057
-31,057
-23% -$1.15M ﹤0.01% 4135
2023
Q1 		$4.83M Buy
137,114
+104,204
+317% +$4.25M ﹤0.01% 3525
2022
Q4 		$1.51M Sell
32,910
-27,561
-46% -$1.19M ﹤0.01% 5267
2022
Q3 		$2.93M Buy
60,471
+39,490
+188% +$1.9M ﹤0.01% 4152
2022
Q2 		$824K Sell
20,981
-25,227
-55% -$1.02M ﹤0.01% 7007
2022
Q1 		$1.7M Sell
46,208
-72,052
-61% -$2.56M ﹤0.01% 5836
2021
Q4 		$5.39M Buy
118,260
+3,741
+3% +$144K ﹤0.01% 3611
2021
Q3 		$4.09M Buy
114,519
+33,992
+42% +$1M ﹤0.01% 4299
2021
Q2 		$1.59M Buy
80,527
+26,040
+48% +$611K ﹤0.01% 6479
2021
Q1 		$1.27M Buy
54,487
+916
+2% +$19.6K ﹤0.01% 7092
2020
Q4 		$1.11M Sell
53,571
-298,812
-85% -$5.46M ﹤0.01% 6470
2020
Q3 		$7.63M Buy
352,383
+270,015
+328% +$6.32M ﹤0.01% 2529
2020
Q2 		$1.94M Buy
82,368
+32,554
+65% +$610K ﹤0.01% 4560
2020
Q1 		$587K Sell
49,814
-85,174
-63% -$1.09M ﹤0.01% 6572
2019
Q4 		$1.43M Sell
134,988
-26,982
-17% -$277K ﹤0.01% 4877
2019
Q3 		$1.84M Buy
161,970
+38,223
+31% +$480K ﹤0.01% 4377
2019
Q2 		$1.39M Buy
+123,747
New +$1.19M ﹤0.01% 4938
2019
Q1 		– Sell
-60,780
Closed -$447K – 8967
2018
Q4 		$384K Buy
+60,780
New +$446K ﹤0.01% 6537
2018
Q3 		– Sell
-36,686
Closed -$294K – 9362
2018
Q2 		$304K Buy
+36,686
New +$305K ﹤0.01% 7816
2017
Q2 		– Sell
-14,435
Closed -$201K – 9273
2017
Q1 		$185K Sell
14,435
-48,302
-77% -$565K ﹤0.01% 8058
2016
Q4 		$762K Buy
62,737
+49,381
+370% +$524K ﹤0.01% 6098
2016
Q3 		$123K Buy
+13,356
New +$139K ﹤0.01% 7859
2016
Q2 		– Sell
-55,960
Closed -$459K – 8642
2016
Q1 		$395K Buy
+55,960
New +$409K ﹤0.01% 6803
2015
Q4 		– Sell
-13,419
Closed -$132K – 9487
2015
Q3 		$90K Sell
13,419
-11,545
-46% -$78.8K ﹤0.01% 9187
2015
Q2 		$168K Buy
+24,964
New +$164K ﹤0.01% 9424
2015
Q1 		– Sell
-10,551
Closed -$78.8K – 9471
2014
Q4 		$85K Sell
10,551
-65,210
-86% -$280K ﹤0.01% 9239
2014
Q3 		$267K Sell
75,761
-125,791
-62% -$528K ﹤0.01% 8200
2014
Q2 		$964K Buy
201,552
+49,994
+33% +$305K ﹤0.01% 6125
2014
Q1 		$1.44M Buy
151,558
+76,211
+101% +$689K ﹤0.01% 4876
2013
Q4 		$490K Buy
75,347
+42,055
+126% +$276K ﹤0.01% 6723
2013
Q3 		$253K Buy
+33,292
New +$357K ﹤0.01% 7449

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's CYTK Position: Q1 2026 in Review

Susquehanna International Group increased its Cytokinetics (CYTK) stake by 19% in Q1 2026, buying an estimated $9.24M and bringing the position to 898,951 shares worth $59.2M. The position accounts for 0.01% of the portfolio, ranked #1161.

Susquehanna International Group first reported a position in CYTK in Q3 2013 and has held it in 42 quarters since. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Susquehanna International Group held 898,951 shares of Cytokinetics worth $59.2M as of Q1 2026.
  • Susquehanna International Group bought 145,334 Cytokinetics shares in Q1 2026, an estimated $9.24M.
  • Cytokinetics made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1161 holding.
  • Susquehanna International Group first reported a position in Cytokinetics in Q3 2013 and has held it in 42 quarters since.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.